Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)
Clinical trial NCT03208335 · UNKNOWN
Trial details
- NCT number
- NCT03208335
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-12-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.